99 related articles for article (PubMed ID: 16005524)
1. PSGL-1 is not required for development of experimental autoimmune encephalomyelitis.
Osmers I; Bullard DC; Barnum SR
J Neuroimmunol; 2005 Sep; 166(1-2):193-6. PubMed ID: 16005524
[TBL] [Abstract][Full Text] [Related]
2. PSGL-1 is dispensible for the development of active experimental autoimmune encephalomyelitis in SJL/J mice.
Bill R; Döring A; Deutsch U; Engelhardt B
J Neuroimmunol; 2011 Mar; 232(1-2):207-8. PubMed ID: 21051092
[TBL] [Abstract][Full Text] [Related]
3. Immune cell entry into the central nervous system: involvement of adhesion molecules and chemokines.
Engelhardt B
J Neurol Sci; 2008 Nov; 274(1-2):23-6. PubMed ID: 18573502
[TBL] [Abstract][Full Text] [Related]
4. P-selectin glycoprotein ligand-1 mediates L-selectin-independent leukocyte rolling in high endothelial venules of peripheral lymph nodes.
Harakawa N; Shigeta A; Wato M; Merrill-Skoloff G; Furie BC; Furie B; Okazaki T; Domae N; Miyasaka M; Hirata T
Int Immunol; 2007 Mar; 19(3):321-9. PubMed ID: 17267415
[TBL] [Abstract][Full Text] [Related]
5. PSGL-1 and E/P-selectins are essential for T-cell rolling in inflamed CNS microvessels but dispensable for initiation of EAE.
Sathiyanadan K; Coisne C; Enzmann G; Deutsch U; Engelhardt B
Eur J Immunol; 2014 Aug; 44(8):2287-94. PubMed ID: 24740164
[TBL] [Abstract][Full Text] [Related]
6. P-selectin glycoprotein ligand 1 is not required for the development of experimental autoimmune encephalomyelitis in SJL and C57BL/6 mice.
Engelhardt B; Kempe B; Merfeld-Clauss S; Laschinger M; Furie B; Wild MK; Vestweber D
J Immunol; 2005 Jul; 175(2):1267-75. PubMed ID: 16002731
[TBL] [Abstract][Full Text] [Related]
7. CCL2 and CCL5 mediate leukocyte adhesion in experimental autoimmune encephalomyelitis--an intravital microscopy study.
dos Santos AC; Barsante MM; Arantes RM; Bernard CC; Teixeira MM; Carvalho-Tavares J
J Neuroimmunol; 2005 May; 162(1-2):122-9. PubMed ID: 15833367
[TBL] [Abstract][Full Text] [Related]
8. Absence of PAF receptor alters cellular infiltrate but not rolling and adhesion of leukocytes in experimental autoimmune encephalomyelitis.
Rodrigues DH; Lacerda-Queiroz N; de Miranda AS; Fagundes CT; Campos RD; Arantes RE; Vilela Mde C; Rachid MA; Teixeira MM; Teixeira AL
Brain Res; 2011 Apr; 1385():298-306. PubMed ID: 21338585
[TBL] [Abstract][Full Text] [Related]
9. IL-12 driven upregulation of P-selectin ligand on myelin-specific T cells is a critical step in an animal model of autoimmune demyelination.
Deshpande P; King IL; Segal BM
J Neuroimmunol; 2006 Apr; 173(1-2):35-44. PubMed ID: 16413063
[TBL] [Abstract][Full Text] [Related]
10. Absence of PI3Kgamma leads to increased leukocyte apoptosis and diminished severity of experimental autoimmune encephalomyelitis.
Rodrigues DH; Vilela MC; Barcelos LS; Pinho V; Teixeira MM; Teixeira AL
J Neuroimmunol; 2010 May; 222(1-2):90-4. PubMed ID: 20303183
[TBL] [Abstract][Full Text] [Related]
11. Experimental autoimmune encephalomyelitis induction in peptidylarginine deiminase 2 knockout mice.
Raijmakers R; Vogelzangs J; Raats J; Panzenbeck M; Corby M; Jiang H; Thibodeau M; Haynes N; van Venrooij WJ; Pruijn GJ; Werneburg B
J Comp Neurol; 2006 Sep; 498(2):217-26. PubMed ID: 16856138
[TBL] [Abstract][Full Text] [Related]
12. Deficient p75 low-affinity neurotrophin receptor expression does alter the composition of cellular infiltrate in experimental autoimmune encephalomyelitis in C57BL/6 mice.
Küst B; Mantingh-Otter I; Boddeke E; Copray S
J Neuroimmunol; 2006 May; 174(1-2):92-100. PubMed ID: 16519950
[TBL] [Abstract][Full Text] [Related]
13. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis.
Li O; Liu JQ; Zhang H; Zheng P; Liu Y; Bai XF
Scand J Immunol; 2006 Aug; 64(2):117-24. PubMed ID: 16867156
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of CCR6 function reduces the severity of experimental autoimmune encephalomyelitis via effects on the priming phase of the immune response.
Liston A; Kohler RE; Townley S; Haylock-Jacobs S; Comerford I; Caon AC; Webster J; Harrison JM; Swann J; Clark-Lewis I; Korner H; McColl SR
J Immunol; 2009 Mar; 182(5):3121-30. PubMed ID: 19234209
[TBL] [Abstract][Full Text] [Related]
15. Validation of a novel biomarker for acute axonal injury in experimental autoimmune encephalomyelitis.
Gresle MM; Shaw G; Jarrott B; Alexandrou EN; Friedhuber A; Kilpatrick TJ; Butzkueven H
J Neurosci Res; 2008 Dec; 86(16):3548-55. PubMed ID: 18709652
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide and TNFalpha effects in experimental autoimmune encephalomyelitis demyelination.
Farias AS; de la Hoz C; Castro FR; Oliveira EC; Ribeiro dos Reis JR; Silva JS; Langone F; Santos LM
Neuroimmunomodulation; 2007; 14(1):32-8. PubMed ID: 17700038
[TBL] [Abstract][Full Text] [Related]
17. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
Olechowski CJ; Truong JJ; Kerr BJ
Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337
[TBL] [Abstract][Full Text] [Related]
18. 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside attenuates experimental autoimmune encephalomyelitis via modulation of endothelial-monocyte interaction.
Prasad R; Giri S; Nath N; Singh I; Singh AK
J Neurosci Res; 2006 Aug; 84(3):614-25. PubMed ID: 16770773
[TBL] [Abstract][Full Text] [Related]
19. Expression of C5a in the brain does not exacerbate experimental autoimmune encephalomyelitis.
Reiman R; Campos Torres A; Martin BK; Ting JP; Campbell IL; Barnum SR
Neurosci Lett; 2005 Dec; 390(3):134-8. PubMed ID: 16154690
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the timing of acute blood-brain barrier breakdown to rabbit immunoglobulin G in the cerebellum and spinal cord of mice with experimental autoimmune encephalomyelitis.
Tonra JR; Reiseter BS; Kolbeck R; Nagashima K; Robertson R; Keyt B; Lindsay RM
J Comp Neurol; 2001 Jan; 430(1):131-44. PubMed ID: 11135250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
